MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.20
−1.54%Forward multiples
Based on analyst estimates
- P/E forward
- 48.48x
- P/E 2026E
- —
- P/E 2027E
- 45.28x
- P/E 2028E
- 18.45x
- P/S forward
- 1.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.21x
- Price / sales
- 1.54x
- Price / cash flow
- 22.52x
Enterprise value
- Enterprise value
- $346.2M
- EV / sales
- 1.14x
- EV / EBITDA
- -22.38x
- EV / EBIT
- -13.77x
- Market cap
- $467.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026